Found 27 matching trials
IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
PHASE2This study was conducted in order to evaluate the efficacy and safety of th...
Location
Medizinische Universität Salzburg - Universitätsklinik für Innere Medizin III
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
PHASE2The purpose of this study is to evaluate the safety and feasibility of long...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
PHASE3The primary objective of the phase III study is to investigate whether IMA9...
Location
University of Arkansas for Medical Sciences
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
PHASE1The purpose of this study is to assess the safety and tolerability of VBI-1...
Location
University of California, Irvine
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
PHASE2This study will test an investigational vaccine, called DRibbles, for the t...
Location
LSU Stanley S. Scott Cancer Center
Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
PHASE2This Phase II trial evaluates the safety and immunogenicity of two doses of...
Location
Moffitt Cancer Center
REO13 Melanoma With of Without GM-CSF
PHASE1Open-label, non-randomised, single centre study which will assess the prese...
Location
Multiple Locations
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
PHASE1RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Location
Multiple Locations
Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy
NAA single center, randomized controlled trial design was used to select pati...
Location
Henan Provincial People's Hospital
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
PHASE1The purpose of this study is to determine if a vaccine called pTVG-AR can e...
Location
Cancer Institute of New Jersey